$VFF Cashflow Statement | Understand Stock

$VFF

$2.59 +$0.05 (1.97%) Close

$VFF Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows provided by (used in) operating activities:
Net loss attributable to Village Farms International, Inc. shareholders
Loss including non-controlling interests
Income (loss) from continuing operations including non-controlling interests
Adjustments to reconcile loss including non-controlling interests to net cash provided by (used in) operating activities:
Depreciation and amortization
Amortization of deferred charges
Share of loss from joint venture
Net income (loss) attributable to non-controlling interest
Interest expense
Interest income
Interest paid on long-term debt
Unrealized foreign exchange loss
Inventory impairment
Write-off of note receivable
Goodwill and intangible asset impairments
Inventory and other impairments
Write-off of joint venture loan
Loss (gain) on disposal of assets
Non-cash lease expense
Other
Share-based compensation
Deferred income taxes
Changes in non-cash working capital items

Net cash provided by (used in) operating activities
Net cash provided by operating activities from continuing operations
Cash flows (used in) provided by investing activities:
Purchases of property, plant and equipment
Advances to joint ventures
Purchases of intangibles
Acquisitions, net
Investment in minority interests
Equity investment
Issuance of note receivable
Repayment of note receivable
Net cash used in investing activities
Net cash used in investing activities from continuing operations

Cash flows (used in) provided by financing activities:
Proceeds from borrowings
Repayments on borrowings
Purchase of non-controlling interest
Proceeds from issuance of common stock and warrants
Issuance costs
Note payable paid to Emerald Health
Proceeds from exercise of stock options
Proceeds from exercise of warrants
Net cash (used in) provided by financing activities
Share repurchases
Payments on capital lease obligations
Payment of note payable related to acquisition
Proceeds from exercise of warrants and stock options
Other financing activities
Net cash used in (provided by) financing activities from continuing operations

Discontinued Operations
Net cash (used in) provided by operating activities from discontinued operations
Net cash provided by (used in) investing activities from discontinued operations
Net cash used in financing activities from discontinued operations
Net cash flows provided by discontinued operations
Effect of exchange rate changes on cash and cash equivalents
Net increase (decrease) in cash, cash equivalents and restricted cash
Cash, cash equivalents and restricted cash, beginning of period
Cash, cash equivalents and restricted cash, end of period
Supplemental disclosure of non-cash activities:
Non-Cash - investing and financing activities
Shares issued for acquisitions
Operating lease right-of-use assets
Operating lease liabilities

Supplemental cash flow information
Income Taxes Paid

Comments